The Fine Foods challenge: 100 million on the plate to grow with M&A

On the one hand, to increase the products made on behalf of third parties (especially for individual customers) in the pharma and nutraceuticals, also using the synergies with the newly acquired Pharmatek active in cosmetics. On the other hand, along with organic growth, exploit M&A. They are among the focuses of Fine Foods & Pharmaceuticals Ntm, a company that last July passed from AIM to the Star segment of Piazza Affari, in support of the business.

Corporate purpose

Yes, the business. To better understand the company strategy …